Dynavax Technologies Corporation

(DVAX) Trade

By |

Profile

Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. It's current product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. Dynavax operates in the business segment the discovery and development of biopharmaceutical products. Its Toll-like Receptor Immune Modulation Platform technology play a vital role in innate immunity and subsequent adaptive immunity. Signaling through these receptors is triggered by the binding of a variety of pathogen-associated molecules and is essential to the generation of innate immunity.

Contact Information

Website: www.dynavax.com
Email: IR@dynavax.com
Main Phone: +1 510 848-5100
Address: 2929 Seventh Street
Address 2: Suite 100
State: CA
City / Town: Berkeley
Country: USA
Postal Code: 94710-2753

Issuer Information

Exchange: NSC
CEO: Eddie Gray
Employees: 192
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 9.90 $ -0.25 (-2.46%)
Last Price 9.90 Change $ -0.25 Change % -2.46 Tick N/A
Bid 9.86 Bid Size 200.00 Ask 9.90 Ask Size 100.00
Open 10.30 High 10.32 Low 9.89 Prev Close 10.15
Last Trade Volume 108,839 52 Wk Hi 22.80 52 Wk Low 9.63
Market Cap 620.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 62,691,478.00 EPS (TTM) -2.36 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 14 63
Number of Buys 6 29
Number of Sells 8 34
Net Activity 121174 407284
Last 10 Buys Shares
Robert Janssen 1,000
Robert Janssen 1,000
Eddie Gray 1,000
Eddie Gray 1,000
Robert Janssen 1,000
Robert Janssen 1,000
Eddie Gray 1,000
Peggy V. Phillips 1,000
Arnold L. Oronsky 1,000
Daniel L. Kisner 1,000
Last 10 Sell Shares
Michael S. Ostrach 1,000
David Novack 1,000
David Novack 1,000
David Novack 1,000
David Novack 1,000
David Novack 1,000
David Novack 1,000
David Johnson 1,000
Robert L. Coffman 1,000
Robert L. Coffman 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 30 30 30 30
Low Target Price Estimate 27 27 27 27
Mean Target Price Estimate 28 28 28 28
Standard Deviation 1.41 1.41 1.41 1.41
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 06/05/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 3 3
Moderate Buy 1 1 1 1
Hold 0 0 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.2 1.2 1.6 1.6